Peptide profiler
Quick adme quote
Connect with us
Connect your science
Connect your science

We connect you with specific subject matter experts to ensure support and recommendations tailored to your project.

Thank you, your request has been received.

We're busy connecting you with an expert, who will be in touch as soon as possible.

Oops! Something went wrong while submitting the form. Please try again or email us at webenquiries@conceptlifesciences.com
We will respond to you within 24 hours of your enquiry being received.
‍
You can also find Concept Life Sciences on the following platforms:

Cardiotoxicity

Mitigate risks and ensure safety and efficacy

Explore topics
Example H2
Example H3
Resources
Speak to us
Integrated Drug Discovery
Target Validation
Hit Identification
BioPALS
Direct-to-Biology (D2B)
Fragment based drug discovery
Focused screen
Hit to Lead
Lead Optimization
Candidate Selection
Biology
Assay Development & Screening
Assay Development
Screening
Biochemical Screening
Cellular Screening
Biophysical Assays
Biomarkers
Biophysics
Cell Based Assays
3D & ex vivo Models
Cell Health & Proliferation
Disease Modeling
Functional Assays
Target & Pathway Engagement
Molecular Biology
Gene Expression Analysis
Genetic Modification
Transcriptomics
Protein Production
Spatial Biology
Histology
Immunohistochemistry and In Situ Hybridization
Image Analysis
Structural Biology
Chemistry
Synthetic Chemistry
Computer Aided Drug Discovery (CADD)
Medicinal Chemistry
Process Research & Development (PR&D)
GMP Manufacture
Analytical Chemistry
ADMET & DMPK
In vitro ADME Assays
Bioanalysis
In vivo PK Screen
Toxicology
Cardiotoxicity
Cytotoxicity
Hepatotoxicity
Neurotoxicity
work with us

Cardiotoxicity assessments focus on determining adverse effects on the cardiovascular system caused by new chemical entities or therapeutic interventions.

Integrating cardiotoxicity early in the pipeline helps mitigate risks, ensuring the safety and efficacy of potential therapeutics.

Our scientific team and our network of specialist service providers can help you design the most appropriate biochemical and cellular assays using iPSC-derived cardiomyocytes to mitigate risk:

Viability Assays: MTT, ATP-based assays, or LDH release for general cytotoxicity.

Oxidative Stress Markers: ROS detection, lipid peroxidation, or antioxidant levels.

Mitochondrial toxicity: mitochondrial resazurin metabolism

Apoptosis/Necrosis: Annexin V/PI staining, caspase activation assays.

We offer a comprehensive range of instrumentation and cellular systems to help design the most appropriate assay, ensuring alignment with experimental goals and the generation of meaningful data.  

Download and resource links:
Assay Card
ADMET, DMPK and Toxicology

Get started today
Book a meeting with an expert